ID   MYD88_RAT               Reviewed;         296 AA.
AC   Q6Y1S1; Q4QRC0;
DT   23-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   02-OCT-2024, entry version 139.
DE   RecName: Full=Myeloid differentiation primary response protein MyD88;
GN   Name=Myd88;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Spleen;
RA   Li Y., Ji A., Schafer M.K.;
RT   "Molecular cloning and regulation of MyD88 mRNA in rat spleen.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1
CC       receptor signaling pathway in the innate immune response. Acts via
CC       IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation,
CC       cytokine secretion and the inflammatory response. Increases IL-8
CC       transcription. Involved in IL-18-mediated signaling pathway. Activates
CC       IRF1 resulting in its rapid migration into the nucleus to mediate an
CC       efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8
CC       activation by GU-rich single-stranded RNA (GU-rich RNA) derived from
CC       viruses, induces IL1B release through NLRP3 inflammasome activation (By
CC       similarity). MyD88-mediated signaling in intestinal epithelial cells is
CC       crucial for maintenance of gut homeostasis and controls the expression
CC       of the antimicrobial lectin REG3G in the small intestine (By
CC       similarity). {ECO:0000250|UniProtKB:P22366,
CC       ECO:0000250|UniProtKB:Q99836}.
CC   -!- SUBUNIT: Homodimer. Also forms heterodimers with TIRAP. Binds to TLR2,
CC       TLR4, IRAK1, IRAK2 and IRAK4 via their respective TIR domains.
CC       Interacts with IL18R1. Interacts with BMX, IL1RL1, IKBKE and IRF7.
CC       Interacts with LRRFIP1 and LRRFIP2; this interaction positively
CC       regulates Toll-like receptor (TLR) signaling in response to agonist.
CC       Interacts with FLII. LRRFIP1 and LRRFIP2 compete with FLII for MYD88-
CC       binding. Interacts with IRF1. Upon IL1B treatment, forms a complex with
CC       PELI1, IRAK1, IRAK4 and TRAF6; this complex recruits MAP3K7/TAK1, TAB1
CC       and TAB2 to mediate NF-kappa-B activation. Direct binding of SMAD6 to
CC       PELI1 prevents the complex formation and hence negatively regulates
CC       IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression.
CC       May interact with PIK3AP1. Interacts (via TIR domain) with DHX9 (via
CC       H2A and OB-fold regions); this interaction is direct. Interacts with
CC       OTUD4 deubiquitinase; the interaction is direct.
CC       {ECO:0000250|UniProtKB:Q99836}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q99836}. Nucleus
CC       {ECO:0000250|UniProtKB:Q99836}.
CC   -!- DOMAIN: The intermediate domain (ID) is required for the
CC       phosphorylation and activation of IRAK. {ECO:0000250|UniProtKB:P22366}.
CC   -!- PTM: Ubiquitinated; undergoes 'Lys-63'-linked polyubiquitination. OTUD4
CC       specifically hydrolyzes 'Lys-63'-linked polyubiquitinated MYD88.
CC       Deubiquitinated by USP3 that cleaves 'Lys-63'-linked ubiquitin chains
CC       leading to inhibition of MYD88-induced NF-kappa-B signaling.
CC       {ECO:0000250|UniProtKB:Q99836}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY191270; AAO91937.1; -; mRNA.
DR   EMBL; BC097266; AAH97266.1; -; mRNA.
DR   RefSeq; NP_937763.1; NM_198130.1.
DR   RefSeq; XP_006244149.1; XM_006244087.3.
DR   AlphaFoldDB; Q6Y1S1; -.
DR   SMR; Q6Y1S1; -.
DR   STRING; 10116.ENSRNOP00000018341; -.
DR   PhosphoSitePlus; Q6Y1S1; -.
DR   PaxDb; 10116-ENSRNOP00000018341; -.
DR   Ensembl; ENSRNOT00000018341.6; ENSRNOP00000018341.3; ENSRNOG00000013634.6.
DR   GeneID; 301059; -.
DR   KEGG; rno:301059; -.
DR   UCSC; RGD:735043; rat.
DR   AGR; RGD:735043; -.
DR   CTD; 4615; -.
DR   RGD; 735043; Myd88.
DR   eggNOG; ENOG502QWKI; Eukaryota.
DR   GeneTree; ENSGT00510000048324; -.
DR   HOGENOM; CLU_045884_0_0_1; -.
DR   InParanoid; Q6Y1S1; -.
DR   OMA; SNECDFQ; -.
DR   OrthoDB; 2964088at2759; -.
DR   PhylomeDB; Q6Y1S1; -.
DR   TreeFam; TF326264; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1810476; RIP-mediated NFkB activation via ZBP1.
DR   Reactome; R-RNO-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-RNO-3134963; DEx/H-box helicases activate type I IFN and inflammatory cytokines production.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-9020702; Interleukin-1 signaling.
DR   PRO; PR:Q6Y1S1; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000013634; Expressed in spleen and 19 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0140674; F:ATP-dependent histone chaperone activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005149; F:interleukin-1 receptor binding; IPI:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0035591; F:signaling adaptor activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0070976; F:TIR domain binding; ISO:RGD.
DR   GO; GO:0005121; F:Toll binding; IDA:RGD.
DR   GO; GO:0035325; F:Toll-like receptor binding; ISO:RGD.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0140052; P:cellular response to oxidised low-density lipoprotein particle stimulus; ISO:RGD.
DR   GO; GO:0006325; P:chromatin organization; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; ISO:RGD.
DR   GO; GO:0009682; P:induced systemic resistance; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038172; P:interleukin-33-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; IMP:RGD.
DR   GO; GO:0002269; P:leukocyte activation involved in inflammatory response; ISO:RGD.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0014004; P:microglia differentiation; ISO:RGD.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0002283; P:neutrophil activation involved in immune response; ISO:RGD.
DR   GO; GO:0070944; P:neutrophil-mediated killing of bacterium; ISO:RGD.
DR   GO; GO:0006909; P:phagocytosis; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISO:RGD.
DR   GO; GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:UniProtKB.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISO:RGD.
DR   GO; GO:0032747; P:positive regulation of interleukin-23 production; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0050671; P:positive regulation of lymphocyte proliferation; ISO:RGD.
DR   GO; GO:0060907; P:positive regulation of macrophage cytokine production; ISO:RGD.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:2000338; P:regulation of chemokine (C-X-C motif) ligand 1 production; ISO:RGD.
DR   GO; GO:2000341; P:regulation of chemokine (C-X-C motif) ligand 2 production; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:1902622; P:regulation of neutrophil migration; ISO:RGD.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0002238; P:response to molecule of fungal origin; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0032494; P:response to peptidoglycan; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0008063; P:Toll signaling pathway; IDA:RGD.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISO:RGD.
DR   GO; GO:0034158; P:toll-like receptor 8 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; ISO:RGD.
DR   CDD; cd08312; Death_MyD88; 1.
DR   Gene3D; 1.10.533.10; Death Domain, Fas; 1.
DR   Gene3D; 3.40.50.10140; Toll/interleukin-1 receptor homology (TIR) domain; 1.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR034249; MyD88_Death.
DR   InterPro; IPR017281; Myelin_different_resp_MyD88.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR15079; MYD88; 1.
DR   PANTHER; PTHR15079:SF3; MYELOID DIFFERENTIATION PRIMARY RESPONSE PROTEIN MYD88; 1.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF13676; TIR_2; 1.
DR   PIRSF; PIRSF037756; MyD88; 1.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF47986; DEATH domain; 1.
DR   SUPFAM; SSF52200; Toll/Interleukin receptor TIR domain; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS50104; TIR; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; Immunity; Inflammatory response; Innate immunity; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..296
FT                   /note="Myeloid differentiation primary response protein
FT                   MyD88"
FT                   /id="PRO_0000393138"
FT   DOMAIN          32..109
FT                   /note="Death"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00064"
FT   DOMAIN          159..293
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   REGION          110..155
FT                   /note="Intermediate domain"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99836"
FT   CONFLICT        170
FT                   /note="S -> N (in Ref. 1; AAO91937)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   296 AA;  33856 MW;  6B84304BF7EDB010 CRC64;
     MSAGGPRVGS VSVDSYLFSL PLVALNVGVR RRLSLFLNPR TTAAADWTSL AEEMGFEYLE
     IREFETRPDP TRSLLDAWQG RSGSSVGRLL ELLALLDRED ILYELKDRIE EDCQKYIRNQ
     QKQESEKPLQ VARVESSVPQ TKELGGITTL DDPLGQTPEL FDAFICYCPS DIEFVQEMIR
     QLEQTDYRLK LCVSDRDVLP GTCVWSIASE LIEKRCRRMV VVVSDDYLQS KECDFQTKFA
     LSLSPGVQQK RLIPIKYKAM KKDFPSILRF ITICDYTNPC TKSWFWTRLA KALSLP
//
